UPC Analytics
ENDE
Overview · Filed:

UPC_APP_907/2025

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Procedural & sub-applicationsOther ProceduralMunich LDApplication Rop305
  • 2025-01-17Procedural onlyproceduralApplication Rop305

    The Munich Local Division issued a procedural order in multiple related infringement actions by Sanofi against various generic manufacturers (Accord, STADA, Dr. Reddy's, Zentiva) concerning EP 2 493 466. The order addressed the substitution of Sanofi Mature IP by Sanofi SA as new patent proprietor following Sanofi Mature IP's dissolution, and the consequential procedural steps under R. 310 RoP.